P, L., MK, B., BM, B., BC, C., & JE, T. (2021). Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation. Ocular immunology and inflammation, 29(7-8), 1564. https://doi.org/10.1080/09273948.2020.1749857
Chicago Style (17th ed.) CitationP, Liberman, Berkenstock MK, Burkholder BM, Chaon BC, and Thorne JE. "Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation." Ocular Immunology and Inflammation 29, no. 7-8 (2021): 1564. https://doi.org/10.1080/09273948.2020.1749857.
MLA (9th ed.) CitationP, Liberman, et al. "Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation." Ocular Immunology and Inflammation, vol. 29, no. 7-8, 2021, p. 1564, https://doi.org/10.1080/09273948.2020.1749857.
Warning: These citations may not always be 100% accurate.